Global Psoriasis Drug Market Insights, Forecast to 2025

Global Psoriasis Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Psoriasis Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Psoriasis Drug Market Size Growth Rate by Product
1.4.2 External Use
1.4.3 Oral
1.4.4 Injection
1.5 Market by End User
1.5.1 Global Psoriasis Drug Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Drugs Store
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Psoriasis Drug Market Size
2.1.1 Global Psoriasis Drug Revenue 2014-2025
2.1.2 Global Psoriasis Drug Sales 2014-2025
2.2 Psoriasis Drug Growth Rate by Regions
2.2.1 Global Psoriasis Drug Sales by Regions
2.2.2 Global Psoriasis Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Psoriasis Drug Sales by Manufacturers
3.1.1 Psoriasis Drug Sales by Manufacturers
3.1.2 Psoriasis Drug Sales Market Share by Manufacturers
3.1.3 Global Psoriasis Drug Market Concentration Ratio (CR5 and HHI)
3.2 Psoriasis Drug Revenue by Manufacturers
3.2.1 Psoriasis Drug Revenue by Manufacturers (2014-2019)
3.2.2 Psoriasis Drug Revenue Share by Manufacturers (2014-2019)
3.3 Psoriasis Drug Price by Manufacturers
3.4 Psoriasis Drug Manufacturing Base Distribution, Product Types
3.4.1 Psoriasis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Psoriasis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Psoriasis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Psoriasis Drug Sales by Product
4.2 Global Psoriasis Drug Revenue by Product
4.3 Psoriasis Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Psoriasis Drug Breakdown Data by End User
6 North America
6.1 North America Psoriasis Drug by Countries
6.1.1 North America Psoriasis Drug Sales by Countries
6.1.2 North America Psoriasis Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Psoriasis Drug by Product
6.3 North America Psoriasis Drug by End User
7 Europe
7.1 Europe Psoriasis Drug by Countries
7.1.1 Europe Psoriasis Drug Sales by Countries
7.1.2 Europe Psoriasis Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Psoriasis Drug by Product
7.3 Europe Psoriasis Drug by End User
8 Asia Pacific
8.1 Asia Pacific Psoriasis Drug by Countries
8.1.1 Asia Pacific Psoriasis Drug Sales by Countries
8.1.2 Asia Pacific Psoriasis Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Psoriasis Drug by Product
8.3 Asia Pacific Psoriasis Drug by End User
9 Central & South America
9.1 Central & South America Psoriasis Drug by Countries
9.1.1 Central & South America Psoriasis Drug Sales by Countries
9.1.2 Central & South America Psoriasis Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Psoriasis Drug by Product
9.3 Central & South America Psoriasis Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Psoriasis Drug by Countries
10.1.1 Middle East and Africa Psoriasis Drug Sales by Countries
10.1.2 Middle East and Africa Psoriasis Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Psoriasis Drug by Product
10.3 Middle East and Africa Psoriasis Drug by End User
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Psoriasis Drug Products Offered
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Business Overview
11.2.3 Johnson & Johnson Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Johnson & Johnson Psoriasis Drug Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Psoriasis Drug Products Offered
11.3.5 Bayer Recent Development
11.4 Galderma
11.4.1 Galderma Company Details
11.4.2 Company Business Overview
11.4.3 Galderma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Galderma Psoriasis Drug Products Offered
11.4.5 Galderma Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Company Business Overview
11.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bristol-Myers Squibb Psoriasis Drug Products Offered
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis Psoriasis Drug Products Offered
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer Psoriasis Drug Products Offered
11.7.5 Pfizer Recent Development
11.8 Merz Pharma
11.8.1 Merz Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Merz Pharma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merz Pharma Psoriasis Drug Products Offered
11.8.5 Merz Pharma Recent Development
11.9 Valeant
11.9.1 Valeant Company Details
11.9.2 Company Business Overview
11.9.3 Valeant Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Valeant Psoriasis Drug Products Offered
11.9.5 Valeant Recent Development
11.10 LEO Pharma
11.10.1 LEO Pharma Company Details
11.10.2 Company Business Overview
11.10.3 LEO Pharma Psoriasis Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 LEO Pharma Psoriasis Drug Products Offered
11.10.5 LEO Pharma Recent Development
11.11 GlaxoSmithKline
12 Future Forecast
12.1 Psoriasis Drug Market Forecast by Regions
12.1.1 Global Psoriasis Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Psoriasis Drug Revenue Forecast by Regions 2019-2025
12.2 Psoriasis Drug Market Forecast by Product
12.2.1 Global Psoriasis Drug Sales Forecast by Product 2019-2025
12.2.2 Global Psoriasis Drug Revenue Forecast by Product 2019-2025
12.3 Psoriasis Drug Market Forecast by End User
12.4 North America Psoriasis Drug Forecast
12.5 Europe Psoriasis Drug Forecast
12.6 Asia Pacific Psoriasis Drug Forecast
12.7 Central & South America Psoriasis Drug Forecast
12.8 Middle East and Africa Psoriasis Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Psoriasis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Psoriasis Drug Product Picture
Table Psoriasis Drug Market Segments
Table Key Manufacturers Psoriasis Drug Covered
Table Global Psoriasis Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Psoriasis Drug Sales Market Share by Product 2014-2025
Figure External Use Product Picture
Table Major Manufacturers of External Use
Figure Oral Product Picture
Table Major Manufacturers of Oral
Figure Injection Product Picture
Table Major Manufacturers of Injection
Table Global Psoriasis Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Drugs Store
Figure Psoriasis Drug Report Years Considered
Figure Global Psoriasis Drug Market Size 2014-2025 (Million US$)
Figure Global Psoriasis Drug Sales 2014-2025 (K Units)
Table Global Psoriasis Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Psoriasis Drug Sales by Regions 2014-2019 (K Units)
Table Global Psoriasis Drug Sales Market Share by Regions 2014-2019
Figure Global Psoriasis Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Psoriasis Drug Sales Market Share by Regions
Table Global Psoriasis Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Psoriasis Drug Revenue Market Share by Regions 2014-2019
Figure Global Psoriasis Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Psoriasis Drug Revenue Market Share by Regions
Table Global Psoriasis Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Psoriasis Drug Sales Share by Manufacturers (2014-2019)
Figure Global Psoriasis Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Psoriasis Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Psoriasis Drug Revenue Share by Manufacturers (2014-2019)
Figure Psoriasis Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Psoriasis Drug Price (2014-2019) (USD/Unit)
Table Psoriasis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Psoriasis Drug Product Type
Table Date of International Manufacturers Enter into Psoriasis Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table Global Psoriasis Drug Sales Share by Product (2014-2019)
Figure Global Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure Global Psoriasis Drug Sales Market Share by Product in 2018
Table Global Psoriasis Drug Revenue by Product (2014-2019) (Million US$)
Table Global Psoriasis Drug Revenue Share by Product (2014-2019)
Figure Global Psoriasis Drug Revenue Market Share by Product (2014-2019)
Figure Global Psoriasis Drug Revenue Market Share by Product in 2018
Table Psoriasis Drug Price by Product 2014-2019 (USD/Unit)
Table Global Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table Global Psoriasis Drug Sales Share by End User (2014-2019)
Figure Global Sales Psoriasis Drug Market Share by End User (2014-2019)
Figure Global Sales Psoriasis Drug Market Share by End User in 2018
Figure North America Psoriasis Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Psoriasis Drug Sales by Countries (2014-2019) (K Units)
Table North America Psoriasis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Psoriasis Drug Sales Market Share by Countries
Table North America Psoriasis Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Psoriasis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Psoriasis Drug Revenue Market Share by Countries
Figure United States Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Psoriasis Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table North America Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Psoriasis Drug Market Share by Product
Table North America Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table North America Psoriasis Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Psoriasis Drug Market Share by End User
Figure Europe Psoriasis Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Psoriasis Drug Sales by Countries (2014-2019) (K Units)
Table Europe Psoriasis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Psoriasis Drug Sales Market Share by Countries
Table Europe Psoriasis Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Psoriasis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Psoriasis Drug Revenue Market Share by Countries
Figure Germany Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table Europe Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Psoriasis Drug Market Share by Product
Table Europe Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table Europe Psoriasis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Psoriasis Drug Market Share by End User
Figure Asia Pacific Psoriasis Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Psoriasis Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Psoriasis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Psoriasis Drug Sales Market Share by Countries
Table Asia Pacific Psoriasis Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Psoriasis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Psoriasis Drug Revenue Market Share by Countries
Figure China Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Psoriasis Drug Market Share by Product
Table Asia Pacific Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Psoriasis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Psoriasis Drug Market Share by End User
Figure Central & South America Psoriasis Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Psoriasis Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Psoriasis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Psoriasis Drug Sales Market Share by Countries
Table Central & South America Psoriasis Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Psoriasis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Psoriasis Drug Revenue Market Share by Countries
Figure Brazil Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Psoriasis Drug Market Share by Product
Table Central & South America Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Psoriasis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Psoriasis Drug Market Share by End User
Figure Middle East and Africa Psoriasis Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Psoriasis Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Psoriasis Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Psoriasis Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Psoriasis Drug Sales Market Share by Countries
Table Middle East and Africa Psoriasis Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Psoriasis Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Psoriasis Drug Revenue Market Share by Countries
Figure GCC Countries Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Psoriasis Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Psoriasis Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Psoriasis Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Psoriasis Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Psoriasis Drug Market Share by Product
Table Middle East and Africa Psoriasis Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Psoriasis Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Psoriasis Drug Market Share by End User
Table AbbVie Company Details
Table AbbVie Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Bayer Company Details
Table Bayer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Galderma Company Details
Table Galderma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Galderma Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Merz Pharma Company Details
Table Merz Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merz Pharma Recent Development
Table Valeant Company Details
Table Valeant Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Recent Development
Table LEO Pharma Company Details
Table LEO Pharma Psoriasis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LEO Pharma Recent Development
Table GlaxoSmithKline Company Details
Table Global Psoriasis Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Psoriasis Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Psoriasis Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Psoriasis Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Psoriasis Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Psoriasis Drug Sales Market Share Forecast by Product 2019-2025
Table Global Psoriasis Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Psoriasis Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Psoriasis Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Psoriasis Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Psoriasis Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Psoriasis Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Psoriasis Drug Value Chain
Table Psoriasis Drug Customers List
Table Psoriasis Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs